We are 2-Ethoxybenzoic acid CAS:134-11-2 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 2-Ethoxybenzoic acid
Benzoic acid, 2-ethoxy-
Molecular Formula: C9H10O3
Molecular Weight: 166.17400
Physical and Chemical Properties:
Density: 1.105 g / mL at 25 ° C (lit.)
Boiling point: 174-176 ° C15 mm Hg (lit.)
Melting point: 19.3-19.5 ° C (lit.)
Flash point:> 230 ° F
Refractive index: n20 / D 1.54 (lit.)
Appearance: Yellow to brown Liquid
25kg cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Sildenafil citrate CAS:171599-83-0
Related News: Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.N- [2- (2,4,6-triclorofenoxi) etil] propan-1-amina CAS:67747-01-7 Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.1,2,2,3-tetracloropropano CAS:13116-53-5 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.(R)-Azepan-3-amine CAS:124932-43-0 Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.